profit from every €100 of sales.
€0€100
Garofalo Health Care
€5.20-3.35% today
-6.5% since Dec 21, 25
1-year low €4.421-year high €5.72
Trading in the middle of its range for the past year.
The essentials
Four questions every investor asks, answered in one line each.
more sales each year, on average, 2022 to 2025.
0%20% a year
You pay €19.64 for every €1 of profit it makes in a year.
CheapExpensive
of earnings would pay off all its debt.
No debt5 years
Money in, money out
What Garofalo Health Care sold, what it kept, and what it did with the cash.
Sales went from €320 million in 2022 to €485 million in 2025, with €23.4 million of profit last year.
SalesProfit
Garofalo Health Care handed back 57% of the cash it generated last year.
€8M
Free cash flow 2025€16M
Bought back its own shares€1M
Paid as dividends€8M
Cash vs. debt€20M vs. €225M
Garofalo Health Care vs. similar companies
Garofalo Health Care grows in the middle of these 5 and is priced in the middle for its profits.
| Company | Profit from €100 of sales | Sales growth a year | Price per €1 of profit |
|---|---|---|---|
| Garofalo Health Care | 19.6× · Fair price | ||
 HCA Healthcare | 15.4× · Fair price | ||
 Fresenius SE & Co. KGaA | 23.9× · Fair price | ||
 IHH Healthcare Berhad | 34.3× · Expensive | ||
 Rede D'Or São Luiz | 16.2× · Fair price |
AI analysis
An AI analyst reads Garofalo Health Care's last five years, its segments, earnings, insiders and peers, and writes the bull case, the bear case and what the price expects.
Run the AI analysisFull statementsIncome, balance sheet and cash flow, year by year
Income statement
| In millions of EUR | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| 320 | 366 | 468 | 485 | |
| 275 | 316 | 398 | 410 | |
| 37 | 46 | 55 | 55 | |
| 50 | 61 | 70 | 73 | |
| 21 | 21 | 22 | 23 | |
| 0.24 | 0.18 | 0.24 | 0.26 | |
| 86.0% | 86.4% | 85.0% | 84.6% | |
| 11.7% | 12.7% | 11.7% | 11.4% | |
| 6.7% | 5.7% | 4.6% | 4.8% |
Balance sheet
| In millions of EUR | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| Total assets | 646 | 796 | 850 | 860 |
| Cash | 31 | 23 | 27 | 20 |
| Total debt | 176 | 228 | 230 | 225 |
| Total liabilities | 367 | 495 | 517 | 510 |
| 279 | 299 | 322 | 339 | |
| 89 | 89 | 90 | 90 | |
| 5.3% | 5.7% | 6.1% | 6.0% | |
| 7.7% | 7.0% | 6.7% | 6.9% |
Cash flow
| In millions of EUR | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| 44 | 50 | 35 | 49 | |
| 15 | 17 | 22 | 34 | |
| 29 | 33 | 13 | 16 | |
| Dividends paid | – | – | – | 8 |
| 3 | 1 | 1 | 1 | |
| – | – | – | – |
Valuation
- 19.6×
- –
- 7.26
- 1.4×
- 0.9×
- 29.7×
- 9.2×
- 3.4%
- 5.1%
- 1.7%
Profitability
- 84.6%
- 11.4%
- 4.8%
- –
- 6.0%
- 5.8%
- –
- –
- –
- –
Growth
- +14.9%
- +2.7%
- –
- –
- +0.4%
Financial health
- 2.8×
- 0.67
- –
- 4.1×
- 1.23
- –
- –
How it ranks in Healthcare
Each dot is where the company stands among every company over $300M in the sector. Further right is better.
Top 47%of 952
Top 45%of 883
Top 34%of 601
Top 36%of 888
Top 33%of 987
1.7%of the share price, paid each year
On $1,000 invested$17a year at today's yield, before tax
–per share
Raised–not every year
How safe it looks
32.4% of its profit
Room to growStretchedMore than it earns: 48.9%
News
No recent news on file.
Insider trades
Our insider feed has not updated since May 26, 2026. Trades filed after that are not listed yet.
No insider trades on file.
The seven classic investing rulebooks
1/7Passes 1 of 7. Each bar is how well the company fits that investor's published rules, from 0 to 100; 60 or more counts as a pass.
Warren Buffett
49No pass
Benjamin Graham
67Pass
Philip Fisher
51No pass
Peter Lynch
25No pass
Joel Greenblatt
34No pass
Charlie Munger
33No pass
Terry Smith
31No pass
Questions about Garofalo Health Care
Is Garofalo Health Care a good stock to buy?
A business with weak numbers at a fair price. 1 of the 7 famous investors' published rulebooks we apply pass it. Whether it suits you depends on your goals and the price you pay; invest-like never tells anyone to buy or sell. The AI analysis lays out the case for and against. Read the Garofalo Health Care AI analysis
What does Garofalo Health Care do?
Garofalo Health Care S.p.A., together with its subsidiaries, operates healthcare clinics in Italy. It operates through Hospital and Social/Dependency Care segments. It is in Medical Care Facilities, based in Rome, RM, Italy, with 2,329 employees.
Does Garofalo Health Care pay a dividend?
Yes. At today's price the dividend is 1.7% a year, about 32% of its yearly profit. In 2025 it paid out €7.59 million in dividends.
Is Garofalo Health Care stock halal?
No. Garofalo Health Care does not pass our halal screen: its debt is 49% of its market value, at or above the 33% limit. How we check
Who are Garofalo Health Care's competitors?
The largest listed companies in the same industry are HCA Healthcare, Fresenius SE & Co. KGaA, IHH Healthcare Berhad and Rede D'Or São Luiz. The peers table on this page compares their profit, growth and price with Garofalo Health Care's.
Prices: daily closes to Nov 13, 2026. Fundamentals: company reports via invest-like data.